New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
05:00 EDTMKGAYMerck KGaA says European Commission approves update of Erbitux
Merck KGaA announced that the European Commission has approved the Type II variation to amend the Erbitux product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer.
News For MKGAY From The Last 14 Days
Check below for free stories on MKGAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MKGAY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use